Literature DB >> 15664858

N-Arylalkylpiperidine urea derivatives as CC chemokine receptor-3 (CCR3) antagonists.

Douglas G Batt1, Gregory C Houghton, John Roderick, Joseph B Santella, Dean A Wacker, Patricia K Welch, Yevgeniya I Orlovsky, Eric A Wadman, James M Trzaskos, Paul Davies, Carl P Decicco, Percy H Carter.   

Abstract

The synthesis and structure-activity relationships of N-arylalkylpiperidylmethyl ureas as antagonists of the CC chemokine receptor-3 (CCR3) are presented. These compounds displayed potent binding to the receptor as well as functional antagonism of eotaxin-elicited effects on eosinophils.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15664858     DOI: 10.1016/j.bmcl.2004.11.006

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

1.  New drugs targeting Th2 lymphocytes in asthma.

Authors:  Gaetano Caramori; David Groneberg; Kazuhiro Ito; Paolo Casolari; Ian M Adcock; Alberto Papi
Journal:  J Occup Med Toxicol       Date:  2008-02-27       Impact factor: 2.646

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.